JPWO2019178546A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019178546A5
JPWO2019178546A5 JP2020573089A JP2020573089A JPWO2019178546A5 JP WO2019178546 A5 JPWO2019178546 A5 JP WO2019178546A5 JP 2020573089 A JP2020573089 A JP 2020573089A JP 2020573089 A JP2020573089 A JP 2020573089A JP WO2019178546 A5 JPWO2019178546 A5 JP WO2019178546A5
Authority
JP
Japan
Prior art keywords
gene expression
subject
response signature
responsive
tnf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020573089A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021518432A5 (https=
JP2021518432A (ja
JP7496324B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/022588 external-priority patent/WO2019178546A1/en
Publication of JP2021518432A publication Critical patent/JP2021518432A/ja
Publication of JP2021518432A5 publication Critical patent/JP2021518432A5/ja
Publication of JPWO2019178546A5 publication Critical patent/JPWO2019178546A5/ja
Application granted granted Critical
Publication of JP7496324B2 publication Critical patent/JP7496324B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020573089A 2018-03-16 2019-03-15 抗ｔｎｆ療法に対する応答性を予測するための方法及びシステム Active JP7496324B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862644070P 2018-03-16 2018-03-16
US62/644,070 2018-03-16
PCT/US2019/022588 WO2019178546A1 (en) 2018-03-16 2019-03-15 Methods and systems for predicting response to anti-tnf therapies

Publications (4)

Publication Number Publication Date
JP2021518432A JP2021518432A (ja) 2021-08-02
JP2021518432A5 JP2021518432A5 (https=) 2022-02-14
JPWO2019178546A5 true JPWO2019178546A5 (https=) 2022-02-14
JP7496324B2 JP7496324B2 (ja) 2024-06-06

Family

ID=67907331

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020573089A Active JP7496324B2 (ja) 2018-03-16 2019-03-15 抗ｔｎｆ療法に対する応答性を予測するための方法及びシステム

Country Status (4)

Country Link
US (3) US11198727B2 (https=)
EP (1) EP3765634A4 (https=)
JP (1) JP7496324B2 (https=)
WO (1) WO2019178546A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019178546A1 (en) 2018-03-16 2019-09-19 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
GB2603294A (en) 2019-06-27 2022-08-03 Scipher Medicine Corp Developing classifiers for stratifying patients
CA3178405A1 (en) 2020-05-14 2021-11-18 Katherine A. OWEN Methods and systems for machine learning analysis of single nucleotide polymorphisms in lupus
IL300978A (en) * 2020-09-01 2023-04-01 Scipher Medicine Corp Methods and systems for predicting response to anti-TNF treatments
IL303198A (en) 2020-11-30 2023-07-01 Mindera Corp Microneedle devices, methods and skin condition tests
EP4015651A1 (en) * 2020-12-17 2022-06-22 Koninklijke Philips N.V. Treatment prediction and effectiveness of anti-tnf alpha treatment in ibd patients
IL305934A (en) * 2021-03-19 2023-11-01 Scipher Medicine Corp Methods for classifying and treating patients
EP4338163A4 (en) 2021-05-13 2024-11-06 Scipher Medicine Corporation ASSESSMENT OF RESPONSE TO THERAPY
MX2023015447A (es) * 2021-06-22 2024-05-09 Scipher Medicine Corp Métodos y sistemas para la supervisión de terapias y el diseño de ensayos.
KR20240044417A (ko) * 2021-06-22 2024-04-04 사이퍼 메디슨 코퍼레이션 개인맞춤형 요법을 위한 방법 및 시스템
WO2024249568A1 (en) 2023-05-30 2024-12-05 Paragon Therapeutics, Inc. Alpha4beta7 integrin antibody compositions and methods of use
CN121889424A (zh) 2023-08-14 2026-04-17 派拉冈医疗公司 α4β7整联蛋白结合蛋白及使用方法
GB202410224D0 (en) * 2024-07-12 2024-08-28 Univ London Queen Mary Method for treating rhematoid arthritis

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040120952A1 (en) * 2000-08-07 2004-06-24 Centocor, Inc Anti-TNF antibodies and peptides of human tumor necrosis factor
AU2006294477A1 (en) 2005-09-27 2007-04-05 Source Mdx Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
NZ567286A (en) 2005-11-01 2012-03-30 Abbott Biotechnolgy Ltd Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
US20080026485A1 (en) 2006-04-18 2008-01-31 Wolfgang Hueber Antibody profiling for determination of patient responsiveness
EP2679996A1 (en) 2007-05-31 2014-01-01 AbbVie Inc. Biomarkers predictive of the responsiveness to TNF-alfa inhibitors in autoimmune disorders
JP5719591B2 (ja) * 2007-06-08 2015-05-20 バイオジェン アイデック エムエー インコーポレイティドＢｉｏｇｅｎ Ｉｄｅｃ Ｉｎｃ． 抗ｔｎｆ応答性または非応答性を予測するためのバイオマーカー
US7863021B2 (en) 2007-09-05 2011-01-04 Celera Corporation Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
WO2009102957A2 (en) 2008-02-14 2009-08-20 The Johns Hopkins University Methods to connect gene set expression profiles to drug sensitivity
EP2307563B1 (en) * 2008-03-28 2014-08-06 Katholieke Universiteit Leuven KU Leuven Research & Development Mucosal gene signatures
CN102171365B (zh) 2008-08-25 2014-01-29 森托科尔奥索生物科技公司 用于溃疡性结肠炎和相关疾病的抗tnf治疗的生物标记物
WO2010025961A2 (en) 2008-09-03 2010-03-11 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin Computer implemented model of biological networks
EP2337861A4 (en) 2008-10-10 2013-06-26 Mount Sinai Hospital Corp METHOD FOR CLASSIFYING SAMPLES ON NETWORK MODULAR BASIS
US8728730B2 (en) 2009-09-03 2014-05-20 Genentech, Inc. Methods for treating, diagnosing, and monitoring rheumatoid arthritis
CA2777800C (en) 2009-10-15 2019-11-12 Crescendo Bioscience Biomarkers and methods for measuring and monitoring inflammatory disease activity
EP2564340B1 (en) 2010-04-29 2020-01-08 The Regents of The University of California Pathway recognition algorithm using data integration on genomic models (paradigm)
US10192641B2 (en) 2010-04-29 2019-01-29 The Regents Of The University Of California Method of generating a dynamic pathway map
WO2012066536A2 (en) * 2010-11-16 2012-05-24 Prediguard Transcriptome signatures discriminate etanercept-treated rheumatoid arthritis (ra) patients according to their response or refractory status
US20130040835A1 (en) * 2011-05-05 2013-02-14 Exagen Diagnostics, Inc Genes predictive of anti-TNF response in inflammatory diseases
JP2014517279A (ja) 2011-05-10 2014-07-17 ネステク ソシエテ アノニム 個別治療管理のための疾患活動性プロファイリングの方法
CN104955845B (zh) 2012-09-27 2018-11-16 美国政府(由卫生和人类服务部的部长所代表) 间皮素抗体和引起有效的抗肿瘤活性的方法
HU230680B1 (hu) * 2012-10-19 2017-08-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Diagnosztikai eljárás
CA2890161A1 (en) 2012-11-05 2014-05-08 Novigenix Sa Biomarker combinations for colorectal tumors
EP2922861A4 (en) 2012-11-26 2016-09-14 Caris Life Sciences Switzerland Holdings Gmbh BIOMARKER COMPOSITIONS AND METHODS
US10161936B2 (en) 2013-03-08 2018-12-25 University Of Leipzig Method and kit for cytokine analysis from a human whole blood sample
WO2014186761A2 (en) 2013-05-17 2014-11-20 The Board Of Trustes Of The Leland Stanford Junior University Methods for determining responsiveness to an anti-cd47 agent
US20160162657A1 (en) 2013-07-08 2016-06-09 Northeastern University Methods For Identifying Complex Disease Subtypes
CA2922732A1 (en) 2013-09-03 2015-03-12 L. Douglas GRAHAM Treatment methods for rheumatoid arthritis
US20160232279A1 (en) 2013-09-23 2016-08-11 Northeastern University System and Methods for Disease Module Detection
CA2943821A1 (en) 2014-04-02 2015-10-08 Crescendo Bioscience Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity
US9753041B2 (en) 2014-04-21 2017-09-05 Univeristy Of South Florida Salivary inflammatory biomarkers associated with glycemic control and oral health
MX2017004742A (es) 2014-10-20 2017-07-20 Nestec Sa Métodos para la predicción de niveles de farmacos anti-tnf alfa y formación de autoanticuerpos.
CA2969326A1 (en) 2014-12-02 2016-06-09 Nestec S.A. Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease
HK1257443A1 (zh) 2015-08-21 2019-10-18 The Children's Hospital Of Philadelphia 治疗具有dcr3或dcr3网络基因中的遗传变异的患者的自身免疫病症的方法
US10018637B2 (en) 2015-10-06 2018-07-10 Celgene International Ii Sarl Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast
ES2716900T3 (es) * 2015-11-06 2019-06-17 Promise Advanced Proteomics Un método para cuantificar anticuerpos anti-TNF
US20190080051A1 (en) 2015-11-11 2019-03-14 Northeastern University Methods And Systems For Profiling Personalized Biomarker Expression Perturbations
US20170145501A1 (en) * 2015-11-20 2017-05-25 Lasse Folkersen Apparatus and methods of using of biomarkers for predicting tnf-inhibitor response
EP3440579A4 (en) * 2015-11-24 2020-03-25 Klaritos, Inc. INNOVATIVE MODEL OF DELIVERY, PROCESSING AND PAYMENT FOR SPECIALIZED MEDICINES
GB201521357D0 (en) * 2015-12-03 2016-01-20 Univ Liverpool Methods for predicting response to anti-TNF therapy
JP6572120B2 (ja) 2015-12-14 2019-09-04 浜松ホトニクス株式会社 光ビーム照射装置
WO2017151755A1 (en) * 2016-03-02 2017-09-08 Crescendo Bioscience Biomarkers and methods for predicting response to discontinuation of inflammatory disease therapy
WO2017223116A2 (en) 2016-06-20 2017-12-28 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases
EP3654993A4 (en) 2017-07-17 2021-08-25 The Broad Institute, Inc. CELL ATLAS OF HEALTHY HUMAN COLUMN AND HUMAN COLUMN WITH COLITIS ULCEROSA
US20200165677A1 (en) 2017-07-18 2020-05-28 Thaddeus Stappenbeck Methods and uses of inflammatory bowel disease biomarkers
US20190287644A1 (en) 2018-02-15 2019-09-19 Northeastern University Correlation Method To Identify Relevant Genes For Personalized Treatment Of Complex Disease
WO2019178546A1 (en) 2018-03-16 2019-09-19 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
AU2020244763A1 (en) 2019-03-22 2021-09-30 Inflammatix, Inc. Systems and methods for deriving and optimizing classifiers from multiple datasets
CN114026644A (zh) 2019-03-28 2022-02-08 相位基因组学公司 通过测序进行核型分析的系统和方法
GB2603294A (en) 2019-06-27 2022-08-03 Scipher Medicine Corp Developing classifiers for stratifying patients
IL300978A (en) 2020-09-01 2023-04-01 Scipher Medicine Corp Methods and systems for predicting response to anti-TNF treatments
IL305934A (en) 2021-03-19 2023-11-01 Scipher Medicine Corp Methods for classifying and treating patients
WO2023150731A2 (en) 2022-02-04 2023-08-10 Scipher Medicine Corporation Systems and methods for predicting response to anti-tnf therapies

Similar Documents

Publication Publication Date Title
JP2021518432A5 (https=)
AU2023208145B2 (en) Methods of monitoring immunosuppressive therapies in a transplant recipient
Panoulas et al. Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking
US20240199729A1 (en) Methods and systems for predicting response to anti-tnf therapies
GB2603294A (en) Developing classifiers for stratifying patients
Jonsson et al. Mutations in collagen, type XVII, alpha 1 (COL17A1) cause epithelial recurrent erosion dystrophy (ERED)
JP2021503149A (ja) がん治療の有効性を予測するためのシステムおよび方法
JPWO2019178546A5 (https=)
JP2018506528A5 (https=)
US20230282367A1 (en) Methods and systems for predicting response to anti-tnf therapies
JP2019503176A5 (https=)
JPWO2020264426A5 (https=)
GB2622147A (en) Methods of classifying and treating patients
US20240254243A1 (en) Systems and methods for improved targeted therapy
Padilla et al. Kawasaki disease and clinical outcome disparities among black children
Kabakchiev et al. Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis
US20170145501A1 (en) Apparatus and methods of using of biomarkers for predicting tnf-inhibitor response
Lau et al. THU0153 pregnancy outcomes in women exposed to the tumor necrosis factor inhibitor, golimumab
Gunawardana et al. Achieving precision medicine in psoriatic arthritis: novel treatment strategies and trial designs
WO2023061240A1 (zh) 免疫球蛋白A肾病RhoGTPase相关诊断标志物
WO2023061241A1 (zh) 免疫球蛋白a肾病t细胞诊断标志物
Gullu et al. Frequency of Familial Mediterranean Fever Gene Mutation in Patients Presenting With Joint Pain and Diagnosed With Acute Rheumatic Fever
CN115862856A (zh) 甲状腺癌远端转移风险的预测方法、装置
CA2662282A1 (en) A pharmacogenetic method for prediction of the efficacy of methotrexate monotherapy in recent-onset arthritis
Blundell et al. Which Biologic Therapies to Treat Active Rheumatoid Arthritis and When?